Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ”Healthy China”
SHANGHAI, Nov. 8, 2024 /PRNewswire/ — Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th…